KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Vir Biotechnology (VIR) over the last 7 years, with Q3 2025 value amounting to 0.02.

  • Vir Biotechnology's Asset Utilization Ratio fell 6928.67% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 6928.67%. This contributed to the annual value of 0.04 for FY2024, which is 2252.21% up from last year.
  • Latest data reveals that Vir Biotechnology reported Asset Utilization Ratio of 0.02 as of Q3 2025, which was down 6928.67% from 0.02 recorded in Q2 2025.
  • Vir Biotechnology's Asset Utilization Ratio's 5-year high stood at 0.96 during Q1 2022, with a 5-year trough of 0.02 in Q2 2025.
  • In the last 5 years, Vir Biotechnology's Asset Utilization Ratio had a median value of 0.06 in 2023 and averaged 0.27.
  • As far as peak fluctuations go, Vir Biotechnology's Asset Utilization Ratio surged by 190911.76% in 2022, and later tumbled by 9401.6% in 2023.
  • Vir Biotechnology's Asset Utilization Ratio (Quarter) stood at 0.69 in 2021, then decreased by 10.11% to 0.62 in 2022, then plummeted by 92.96% to 0.04 in 2023, then grew by 17.81% to 0.05 in 2024, then crashed by 70.24% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q3 2025, 0.02 for Q2 2025, and 0.02 during Q1 2025.